Want to join the conversation?
For FY17, $HRS expects GAAP diluted income from continuing operations to be in the range of $5.53-5.73 per share and non-GAAP income from continuing operations to be between $5.70-5.90 per diluted share, excluding integration & other acquisition-related charges. The company expects its initial revenue guidance to be between $7.11-7.33Bil for FY17.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?